Next Generation Sequencing System and Support Plan
ID: NIAID-SS-25-2265418Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Set Aside

No Set aside used (NONE)

Original Source

https://sam.gov/opp/ebc816f42278463c89e24bdfc6637458/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a Next Generation Sequencing System and Support Plan under solicitation number NIAID-SS-25-2265418. This procurement aims to acquire a NextSeq 2000 Sequencing System, which is essential for various clinical studies, including viral pathogenesis and the H5N1 Countermeasures Research Project, to enhance research capabilities in combating avian influenza. Interested vendors must submit their quotes by September 19, 2025, at 1:00 P.M. EST, including detailed pricing, shipping information, and compliance with specific technical requirements, with the anticipated period of performance for the support plan running from September 26, 2025, to September 25, 2026. For further inquiries, vendors can contact Shaun Rostad at shaun.rostad@nih.gov or Linda Smith at linda.smith2@nih.gov.

    Files
    Title
    Posted
    Attachment 4 - Statement of Needs.pdf
    The Statement of Need outlines the procurement of a Next Generation Sequencing System with specific technical requirements for a benchtop platform. The system must be compact (under 25in H x 23in W x 26in D, 325lbs) and offer diverse applications including single-cell, whole-exome, and RNA sequencing. Key capabilities include a minimum of 14 configurations, read lengths from 1x50bp to 2x300bp, 10-540Gb output, and 100M-1.8B single-end reads per run in 8-44 hours, utilizing patterned flow cell technology for maximum throughput and cost-efficiency. It must also feature advanced chemistry for faster, higher quality, and more economical sequencing. The workflow needs to be streamlined, requiring less than 10 minutes for setup, no wash cycle interruptions, cloud/on-premises sample tracking, and onboard data analysis under two hours. The system must integrate with 14 or more compatible library prep kits, supporting cloud/on-premises options and scalable sequence generation with exportable outputs. Crucially, the system must ensure seamless compatibility with existing Illumina instrumentation, platforms, and specifically with Illumina XLEAP-SBS™ reagent kits and Illumina Respiratory Virus kits to maintain continuity and accuracy of ongoing studies.
    CSS_NIAID-SS-25-2265418.pdf
    The National Institute of Allergy and Infectious Disease (NIAID) has issued a combined synopsis/solicitation (NIAID-SS-25-2265418) for a Next Generation Sequencing System and Support Plan. This Request for Quotation (RFQ) is for a brand name or equal product, specifically one NextSeq 2000 Sequencing System and a NextSeq 2000 Silver Support Plan. The system is crucial for clinical studies, viral pathogenesis, archaevirology, archaebacteriology, and the H5N1 Countermeasures Research Project. The procurement is a single-award, firm-fixed-price purchase order under Simplified Acquisition Procedures (FAR Part 13) and Acquisition of Commercial Items (FAR Part 12), with a NAICS code of 334516. Quotes are due by September 19, 2025, at 1:00 P.M. EST and must include pricing, shipping, country of origin, vendor authorization, delivery date, point of contact, UEI, CAGE code, business size, and payment terms. Evaluation will prioritize non-price factors like capability, salient characteristics, timely delivery, warranty, past performance, and reasonable price. The period of performance for the support plan is September 26, 2025, to September 25, 2026, with delivery of items within 90 days of order. The document also details invoicing instructions via the Invoice Processing Platform (IPP) and lists numerous applicable FAR and HHSAR provisions and clauses, including those related to ICT accessibility (Section 508).
    Lifecycle
    Title
    Type
    Next Generation Sequencing System and Support Plan
    Combined Synopsis/Solicitation
    Next Generation Sequencing System and Support Plan
    Currently viewing
    Sources Sought
    Similar Opportunities
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    EZ1 & 2 DNA Blood Isolation Kit and DNA Tissue Kit
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole source contract with Qiagen for the procurement of EZ1 & 2 DNA Blood Isolation Kits and DNA Tissue Kits. These kits are critical for the ongoing clinical research and patient care at the NIH Clinical Center, particularly for Human Leukocyte Antigen (HLA) matching in transplant patients and potential donors. The kits have been extensively tested and are essential for providing high-quality DNA samples necessary for critical Next Generation Sequencing, with an estimated contract value of $29,166.25. Interested parties may submit capability statements by email to valerie.gregorio@nih.gov by 11:00 AM EST on December 13, 2025, referencing NOI-CC-26-000013.
    Notice of Intent to Sole Source 2 sets of QX200 ddPCR Systems
    Buyer not available
    The National Institutes of Health (NIH), specifically the Clinical Center (CC), intends to negotiate a sole-source contract for the renewal of maintenance services for two QX200 AutoDG ddPCR Systems from Bio-Rad Laboratories. This five-year service contract, valued at $151,494, is essential for the ongoing maintenance and support of these systems, which are critical for droplet digital PCR (ddPCR) vector copy number detection and gene modification efficiency testing on clinical cellular products. The contract ensures compliance with FDA regulations and is vital for patient care testing, as failure to secure these services could adversely affect patient safety. Interested parties may submit capability statements by December 18, 2025, to valerie.gregorio@nih.gov, referencing NOI-CC-26-000112.
    TheraDoc Hospital Epidemiology System subscription/renewal from Premier Healthcare LLC (Notice of Intent to Sole Source)
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to renew its subscription and support for the TheraDoc Hospital Epidemiology System from Premier Healthcare LLC. This procurement aims to ensure continued access to the TheraDoc clinical surveillance and infection control decision support system, which is vital for patient safety, infection prevention, and regulatory compliance at the NIH Clinical Center. The system aggregates and analyzes data from various clinical sources, providing real-time alerts and reports essential for daily operations. Interested parties may submit capability statements by December 15, 2025, to Lu Chang at lu-chang.lu@nih.gov, as this is a sole-source requirement with a performance period starting October 1, 2025, through September 30, 2026, with two additional option years.
    Preventative Maintenance Agreement for 36 Heracell Vios 160i CO2 incubators
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH), intends to award a firm-fixed-price contract to Thermo Fisher Scientific for a preventative maintenance agreement covering 36 HERA VIOS 160i CO2 incubators. This sole-source acquisition is essential for maintaining critical equipment used in the manufacturing of cell-based therapies, as mandated by the FDA's regulations on controlled maintenance of such equipment. The estimated cost for this project is $55,311.32, and it is crucial for ensuring the continuous, compliant operation of equipment vital for patient care. Interested parties may submit capability statements by email to valerie.gregorio@nih.gov by 11:00 AM EST on December 18, 2025, referencing the notice of intent (NOI-CC-26-000054).
    A--Pre-Sol Notice of Intent
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), has issued a Pre-Solicitation Notice of Intent regarding upcoming procurement opportunities. This notice pertains to research and development services in the physical, engineering, and life sciences sectors, as indicated by the NAICS code 541715. The services sought are crucial for advancing health-related research and healthcare services, contributing to the overall mission of the NIH. For further inquiries, interested parties can contact Lynn M. Furtaw at lynn.furtaw@nih.gov or by phone at +1 301 435 0330.
    All Sites Primary Barrier Equipment and Decontamination Services
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a firm-fixed price contract to provide All Sites Primary Barrier Equipment and Decontamination Services across various NIH locations, including the main campus in Bethesda, MD, and the NIAID Integrated Research Facility in Fort Detrick, MD. The contract aims to support the NIH's comprehensive safety program by ensuring the maintenance and decontamination of equipment used in high-level biosafety laboratories, which is crucial for maintaining a safe environment for research activities. Interested small businesses must submit their proposals by the due date of December 26, 2025, and can direct inquiries to primary contact Evguenia Mathur at jane.mathur@nih.gov or secondary contact Ashley Kinderdine at ashley.kinderdine@nih.gov for further clarification.
    Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells and Human Dorsal Root Ganglion
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified entities to conduct a Single-Nuclei Multiome Analysis of Human Brain Tissue, iPSC-Derived Cells, and Human Dorsal Root Ganglion. This procurement aims to advance research in medical laboratory testing by analyzing complex biological samples to enhance understanding of neurological conditions. The work is critical for developing innovative treatments and therapies in the field of neuroscience. Interested parties can reach out to Maggie Brant at maggie.brant@nih.gov or KJ Shaikh at KJ.Shaikh@nih.gov for further details regarding this opportunity.
    Notice of Intent to Sole Source – Solventum
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Solventum Health Information Systems, Inc. for upgraded platform support and coding, abstracting, and data analysis functions at the NIH Clinical Center's Health Information Management Division. This acquisition is critical as it involves proprietary software that supports existing health information management products, ensuring seamless integration and functionality without the need for extensive rebuilding or retesting of pre-existing interfaces. Interested parties may express their interest and capabilities to the NIH by contacting Kristin Nagashima at kristin.nagashima@nih.gov, with comments due by December 12, 2025, at 12 PM EST.
    A--Biologic Specimen and Data Repositories Information Coordinating Center (BioLIN
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC). This opportunity aims to gather insights on the capabilities and qualifications of potential contractors who can support the management and coordination of biologic specimen and data repositories. The services are critical for advancing health research and ensuring the integrity and accessibility of biological data for various studies. Interested parties can reach out to Natalie E. Bruning at natalie.bruning@nih.gov or by phone at +1 301 827 7528 for further details regarding this sources sought notice.